Overview

Dashboard News

ubs shares decline amid trading losses and upcoming financial results

UBS shares fell by 0.8% to CHF 27.47 at midday, marking a significant loss in the SMI, which is currently at 12,167 points. The stock, which peaked at CHF 28.78 on June 3, 2024, is 4.77% above its 52-week high and 23.99% below its low of CHF 20.88 from October 27, 2023. Analysts anticipate earnings per share of USD 1.64 for 2024, with Q3 2024 results expected on October 30, 2024.
finanzen.ch
Swiss Franc United States Dollar UBS SA CHE Carsten Spohr
TradFi, Market Report
12:29 15.10.2024

ubs initiates buy recommendation for netstreit with significant price upside

UBS has initiated coverage of NETSTREIT (NTST) with a Buy recommendation, projecting a 16.15% upside based on an average one-year price target of $18.60 per share. Institutional ownership has increased by 3.36% in the last quarter, with notable changes in holdings from major shareholders. The company, a Dallas-based REIT, focuses on acquiring single-tenant net lease retail properties, aiming to generate consistent cash flows and dividends.
@Nasdaq
United States Dollar NETSTREIT Corp. USA T. Rowe Price Investment Management Deutsche Bank Ag Cohen & Steers Long Pond Capital Show more
TradFi, Market Report
12:29 15.10.2024

venture capital investment declines significantly in 2023 across europe

2023 marked a significant downturn in venture capital, with only 715 companies raising €8.3 billion, a 38% drop in value. The GreenTech sector led with €2.7 billion, while Fintech and Internet services saw dramatic declines of 73% and 66%, respectively. France maintained its top position in the EU, widening the gap with Germany, which raised €6.6 billion.
EYNews
Euro Mistral SCI Drivecom Amolyt Pharma SAS Verkor SAS Ynsect SAS FRA GBR DEU Mistral AI Driveco Amolyt Pharma Ynsect Verkor Show more
Finance & Economy, Market Report
12:26 15.10.2024

ubs faces pressure to enhance crisis plans after credit suisse acquisition

Finma has mandated UBS to enhance its stabilization and contingency plans following its acquisition of Credit Suisse, emphasizing the need for improved risk management and liquidity strategies. The regulator has temporarily halted approval of these plans, urging UBS to learn from the Credit Suisse crisis, particularly regarding rapid responses to deposit withdrawals. Despite a slight dip in share prices, UBS maintains that it meets current requirements and is actively working to strengthen its liquidation strategies.
Capital Insight
United States Dollar Credit Suisse Anlagestiftung UBS SA CHE
TradFi, Market Report
12:23 15.10.2024

ubs urged to enhance contingency plans after credit suisse takeover

The Swiss financial regulator, Finma, has urged UBS to enhance its stabilization and contingency plans following its acquisition of Credit Suisse. This call comes as UBS is required to ensure its Swiss operations can function uninterrupted during potential insolvency risks, emphasizing the need for improved liquidity measures. UBS has acknowledged the need for targeted development of its contingency strategies in light of lessons learned from the Credit Suisse crisis.
Boursorama
United States Dollar UBS AG Credit Suisse Anlagestiftung CHE Oliver Hirt Tommy Reggiori Wilkes
TradFi, News Article
12:23 15.10.2024

ubs urged to enhance contingency plans after credit suisse takeover

UBS is urged by Swiss regulator Finma to enhance its stabilization and contingency plans following its acquisition of Credit Suisse. The regulator has suspended the annual approval of these plans, emphasizing the need for improved crisis preparedness and liquidity measures to protect financial stability and taxpayer interests. UBS acknowledged the need for targeted development of its contingency strategies to ensure uninterrupted operations during potential insolvency risks.
Challenges
United States Dollar UBS AG Credit Suisse Anlagestiftung CHE Oliver Hirt Tommy Reggiori Wilkes
TradFi, News Article
12:22 15.10.2024

trump and harris diverge on pharmaceutical policies ahead of election

As the election approaches, Vice President Kamala Harris and former President Donald Trump diverge on pharmaceutical policies. Harris aims to expand Medicare's drug price negotiations and has garnered significant industry support, while Trump has shifted to align with industry lobbyists, distancing himself from previous commitments to lower drug prices and eliminate rebates. The pharmaceutical sector faces critical stakes in the upcoming election, with contrasting visions from the two candidates.
BioPharma Dive
PhRMA Apple Inc. Cost Plus Drugs USA Stephen Ubl Mark Cuban Donald Trump Kamala Harris Show more
Regulatory & Legal, News Article
12:19 15.10.2024

EFG Asset Management appoints Damian Burkhardt as senior portfolio manager

EFG Asset Management has appointed Damian Burkhardt as senior portfolio manager for Swiss Equities, effective immediately. Based in Zurich, he will report to Daniel Murray and focus on developing Swiss equities strategies, leveraging his extensive experience from Credit Suisse Asset Management and Lombard Odier Investment Managers. Burkhardt holds a master's degree from the London School of Economics and is a CFA Charterholder.
Private Banker International
Swiss Franc EFG Asset Management AG London School of Economics and Political Science BlackRock Private Equity Partners Lombard Odier Investment Managers University of St. Gallen Credit Suisse Asset Management Funds CHE Damian Burkhardt Daniel Murray Show more
TradFi, Press Release
12:17 15.10.2024

recipharm expands production in france amid shifting global supply chains

Recipharm is expanding its Monts production center in France to manufacture the Moderna vaccine, creating 100 jobs, despite challenges in recruiting skilled talent. The decision to relocate production is driven by economic interests, environmental concerns, and a desire to strengthen national sovereignty in the face of global supply chain vulnerabilities highlighted by the Covid-19 pandemic. The SYMBIOSE project represents a significant investment in the future of French industry, aiming to balance relocation with securing critical supplies from various regions.
EYFrance
Recipharm Monts SAS FRA CHN
Technology & Innovation, Market Report
12:12 15.10.2024

navigating mergers and acquisitions in the evolving life sciences landscape

Life Sciences companies face a dynamic landscape driven by innovations in therapies and technologies, alongside a shift to a buyer's market due to falling valuations. To secure value from M&A and BD&L transactions, firms must minimize risks, analyze past successes, and ensure effective integration processes. Key strategies include defining value drivers, fostering cultural collaboration, leveraging technology, and emphasizing change management to align organizations and enhance synergy.
EYNews
Apple Inc.
Healthcare, Market Report
12:08 15.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Cryptocurrency & Blockchain Regulations Central Bank Actions Market Sentiment Analysis Banking & Investment Regulations Employment Reports Banking Regulations Corporate Responsibility & ESG Anti-Money Laundering (AML) Regulations Inflation Rates & CPI Data Blockchain Technology Adoption Hedge Funds & Private Equity Cryptocurrency Regulations Tokenomics and Crypto Economics Decentralized Finance (DeFi) Innovations Mergers & Acquisitions Emerging Startups Cryptocurrency Developments
Countries:
USA GBR CHE DEU RUS IND CHN CAN ARE FRA JPN SGP TWN ESP MYS BRA LUX KEN THA AUS
Companies:
Coinbase Global, Inc. Apple Inc. NVIDIA Corporation Solana USD Ethereum USD Tesla, Inc. Chainlink USD Bitwise Bitcoin ETF Fidelity Contrafund UBS Group AG BlackRock, Inc. MicroStrategy Inc Delta Air Lines, Inc. Kraken Energy Corp. Ripple USD USD Ripples USD Microsoft Corporation Standard Chartered PLC Novartis AG Bank of America Corporation
Currencies:
United States Dollar Euro Swiss Franc British Pound Sterling Japanese Yen Indian Rupee Swedish Krona Chinese Yuan Canadian Dollar Singapore Dollar South Korean Won New Taiwan Dollar Thai Baht Philippine Peso Russian Ruble Vietnamese Đồng
People:
Donald Trump Elon Musk Ali Martinez Cynthia Lummis Gary Gensler Joe Biden Paul Atkins Brad Garlinghouse Bill Hughes Sr Tim Scott Matt Hougan Jerome Powell Bernie Moreno Elizabeth Warren Laurent Marochini Margaret Harwood-jones Keith Ammon James Howells Jimmy Carter Dave McCormick

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings